-- Scott Roberts
FRIDAY, June 21 (HealthDay News) -- The Plan B "emergency"
contraceptive (levonorgestrel) has been approved by the U.S. Food
and Drug Administration for any female of child-bearing
Thursday's agency announcement followed an April ruling by the
U.S. District Court in New York that the product had to be made
available without restriction, including age.
Plan B is meant to reduce the chances of pregnancy if taken
within 72 hours of unprotected sex or suspected contraceptive
failure. The product was first approved in 2009 as an
over-the-counter option for women 17 and older, and as a
prescription option for younger females.
The product will not end the pregnancy of a female who is
already pregnant, and there is no evidence that it will harm a
developing fetus, the FDA said in a news release. It will not
prevent any sexually transmitted disease, including HIV/AIDS, the
Some females who have taken Plan B have reported these side
effects: nausea, vomiting, stomach pain, headache, dizziness and
breast tenderness. These adverse reactions are similar to those
reported after use of other birth control products, the FDA
Plan B is produced by Teva Women's Health, a unit of the Israeli
drug maker Teva Pharmaceutical Industries.
The FDA has more about
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.